Abstract:Abstract A biphasic dose response curve was observed when the bone marrow-derived cell line FDCP1, used as an indicator line for IL-3 bioassays, was exposed to supernatants from some activated T cell clones but not others. The active component which inhibited proliferation at the higher supernatant concentrations appeared to be IFN-gamma, based on the following observations. 1) Only those culture supernatants which contained IFN-gamma gave a biphasic dose response curve; 2) with these supernatants, an anti-IFN-gamma mAb augmented the proliferation of FDCP1 cells at the higher supernatant concentrations; and 3) rIFN-gamma profoundly inhibited the proliferation of FDCP1 cells stimulated with rIL-3 or rIL-4. rTNF-alpha inhibited FDCP1 proliferation only to a modest extent, yet the combination of rTNF-alpha + rIFN-gamma provided greater inhibition than each agent alone. The proliferation of a second bone marrow-derived cell line, DA1, was not inhibited by rIFN-gamma or rIFN-gamma + rTNF-alpha when stimulated with rIL-3 or recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). Fresh bone marrow cells also showed a suboptimal proliferative response when stimulated with T cell supernatants containing IFN-gamma, and this response was augmented considerably upon the addition of anti-IFN-gamma mAb. Bone marrow cell proliferation was observed upon exposure to rIL-3, rIL-4, or rGM-CSF, and these responses were inhibited by rIFN-gamma; rTNF-alpha also produced a synergistic effect with these cells. Bone marrow cell colony formation stimulated by rIL-3 or rGM-CSF also was inhibited by rIFN-gamma. Colony formation in bone marrow cell cultures was not observed in response to rIL-4. Collectively, these results suggest that Th1 cells, which in addition to IL-3 and GM-CSF also produce IFN-gamma, may regulate hemopoietic cell proliferation and colony formation differently from the way Th2 cells do, which do not produce IFN-gamma.

The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells

Interferon Gamma Inhibits the Differentiation of Mouse Adult Liver and Bone Marrow Hematopoietic Stem Cells by Inhibiting the Activation of Notch Signaling

IFNgamma Induces Expansion of Hematopoietic Progenitor Cells (36.9)

Brief Report: Interferon-Gamma Induces Expansion of Lin(-)Sca-1(+)C-Kit(+) Cells

[Role of IFN-γ in the Regulation of Murine Hemopoiesis].

Regulation of Hematopoietic Stem Cells Differentiation, Self-Renewal, and Quiescence Through the Mtor Signaling Pathway

Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation

Towards an integrated understanding of inflammatory pathway influence on hematopoietic stem and progenitor cell differentiation

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Macrophage-Lineage Cells Negatively Regulate the Hematopoietic Stem Cell Pool in Response to Interferon Gamma at Steady State and During Infection.

Hemgn Protects Hematopoietic Stem and Progenitor Cells Against Transplantation Stress Through Negatively Regulating IFN‐ γ Signaling

Irgm1 Protects Hematopoietic Stem Cells by Negative Regulation of Ifn Signaling

The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations

Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant

Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons

Inflammatory Signaling Regulates Embryonic Hematopoietic Stem and Progenitor Cell Production.

IFN-γ–STAT1–iNOS Induces Myeloid Progenitors to Acquire Immunosuppressive Activity

IFN-γ Differentially Regulates Subsets of Gr-1(+)CD11b(+) Myeloid Cells in Chronic Inflammation.

Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection

IFNα activates dormant haematopoietic stem cells in vivo

Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.